Business Advisory Services

/MaRS-Services/Business-Advisory-Services/mainColumnParagraphs/0/image/images.jpg

FOR TECHNOLOGY ENTREPRENEURS

MaRS helps Ontario-based technology companies commercialize early-stage innovations – in information and communications technology, nano- and clean-tech, life sciences, med-tech and beyond.

Our team of professionals – including experienced entrepreneurs and tech-savvy strategists – work with hundreds of clients, offering:
  • Advice, including business strategy, investor readiness, mentorship and entrepreneurship education
  • Market Research, with access to a range of proprietary databases and skilled market analysts
  • Money, through funding for business projects and investments of up to $500,000 in seed capital. We can also help you prepare for and provide contacts to angel networks and other venture capitalists.

CONTACT


FOR SOCIAL ENTREPRENEURS

Innovation is not just about advancing science and technology.

MaRS also helps social entrepreneurs build and grow their businesses – to generate specific social benefits as well as revenue.

Our social innovation team – established in 2007 as SiG@MaRS – offers:

  • Advice, including business planning, marketing and mentorship
  • Resources, through a network of national and international contacts active in social innovation
  • Events, including an annual Social Innovation Summit and Social Finance Forum
How does MaRS fit into a national network called Social innovation Generation (SiG)? Read more here >>

MaRS PICKS

The Economics of Climate Change
The Stern Review Publisher: HM Treasury www.sternreview.org.uk The Review, which reports to the Prime Minister and Chancellor, was commissioned by the Chancellor in July 2005 It has been carried out ...

Read More

Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
Author: Yali Friedman Publisher: Logos Press (Mar. 2008) The book promises to provide a framework for understanding critical issues in biotechnology business development. Albeit US-centric, the book ...

Read More